IL151458A0 - Memno peptides, a process for their preparation and their use - Google Patents

Memno peptides, a process for their preparation and their use

Info

Publication number
IL151458A0
IL151458A0 IL15145801A IL15145801A IL151458A0 IL 151458 A0 IL151458 A0 IL 151458A0 IL 15145801 A IL15145801 A IL 15145801A IL 15145801 A IL15145801 A IL 15145801A IL 151458 A0 IL151458 A0 IL 151458A0
Authority
IL
Israel
Prior art keywords
preparation
memno peptides
memno
peptides
Prior art date
Application number
IL15145801A
Other languages
English (en)
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of IL151458A0 publication Critical patent/IL151458A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL15145801A 2000-02-29 2001-02-15 Memno peptides, a process for their preparation and their use IL151458A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00104114A EP1130027A1 (de) 2000-02-29 2000-02-29 Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben
PCT/EP2001/001661 WO2001064715A2 (en) 2000-02-29 2001-02-15 Memno peptides, a process for their preparation and their use

Publications (1)

Publication Number Publication Date
IL151458A0 true IL151458A0 (en) 2003-04-10

Family

ID=8167973

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15145801A IL151458A0 (en) 2000-02-29 2001-02-15 Memno peptides, a process for their preparation and their use
IL151458A IL151458A (en) 2000-02-29 2002-08-25 From it peptides, a process for their preparation and use

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL151458A IL151458A (en) 2000-02-29 2002-08-25 From it peptides, a process for their preparation and use

Country Status (30)

Country Link
US (1) US6627604B2 (et)
EP (2) EP1130027A1 (et)
JP (1) JP4787449B2 (et)
KR (1) KR100997073B1 (et)
CN (1) CN1274715C (et)
AR (1) AR029808A1 (et)
AT (1) ATE313556T1 (et)
AU (2) AU2001250318B2 (et)
BR (1) BR0108757A (et)
CA (1) CA2401032C (et)
CY (1) CY1105550T1 (et)
CZ (1) CZ303552B6 (et)
DE (1) DE60116063T2 (et)
DK (1) DK1261625T3 (et)
EE (1) EE05406B1 (et)
ES (1) ES2254394T3 (et)
HK (1) HK1052712B (et)
HR (1) HRP20020703B1 (et)
HU (1) HU228067B1 (et)
IL (2) IL151458A0 (et)
ME (1) MEP59108A (et)
MX (1) MXPA02007845A (et)
NO (1) NO329082B1 (et)
NZ (1) NZ521036A (et)
PL (1) PL206818B1 (et)
RU (1) RU2261254C2 (et)
SI (1) SI1261625T1 (et)
SK (1) SK287310B6 (et)
WO (1) WO2001064715A2 (et)
ZA (1) ZA200206841B (et)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1308613B1 (it) 1999-02-17 2002-01-09 Pharmacia & Upjohn Spa Acidi grassi essenziali nella prevenzione di eventi cardiovascolari.
EP1130027A1 (de) * 2000-02-29 2001-09-05 Aventis Pharma Deutschland GmbH Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben
DE10050091A1 (de) * 2000-10-09 2002-04-25 Biotechnolog Forschung Gmbh Casein-Peptidfragmente mit wachstumsbeeinflußender Aktivität auf Zellkulturen
ITMI20010129A1 (it) * 2001-01-25 2002-07-25 Pharmacia & Upjohn Spa Acidi grassi essenziali nella terapia di insufficienza cardiaca e scompenso cardiaco
US7160917B2 (en) * 2002-12-13 2007-01-09 Sanofi-Aventis Deutschland Gmbh Spirobenzofuran lactams and their derivatives, processes for their preparation and use thereof
DE10258650A1 (de) * 2002-12-13 2004-06-24 Aventis Pharma Deutschland Gmbh Neue Spirobenzofuranlactame und ihre Derivate, Verfahren zu ihrer Herstellung und Verwendung derselben
DE102012016127A1 (de) 2011-08-31 2013-02-28 Daniel Elias Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0711157A4 (en) * 1993-08-06 1996-07-31 Smithkline Beecham Corp ENDOTHELIN RECEPTOR ANTAGONISTS
JPH07330622A (ja) * 1994-06-06 1995-12-19 Asahi Chem Ind Co Ltd 新規生理活性物質スタキボシンｄ及びその製法
JPH08283118A (ja) * 1995-04-07 1996-10-29 Kao Corp 美白剤
JPH10251262A (ja) * 1997-01-13 1998-09-22 Mercian Corp プロテアーゼ阻害物質およびその製造方法
DE19731571A1 (de) * 1997-07-23 1999-01-28 Merck Patent Gmbh Endothelin-Rezeptor-Antagonisten
DE19754082A1 (de) * 1997-12-05 1999-06-10 Knoll Ag Methode zur Bekämpfung der Fettleibigkeit
EP1130027A1 (de) * 2000-02-29 2001-09-05 Aventis Pharma Deutschland GmbH Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben

Also Published As

Publication number Publication date
IL151458A (en) 2008-08-07
ME00379B (me) 2011-05-10
SK12262002A3 (sk) 2003-02-04
NO20024105L (no) 2002-10-28
NZ521036A (en) 2004-02-27
EE05406B1 (et) 2011-04-15
CZ20022904A3 (cs) 2002-11-13
RU2261254C2 (ru) 2005-09-27
EE200200480A (et) 2004-02-16
DE60116063D1 (de) 2006-01-26
NO329082B1 (no) 2010-08-16
DK1261625T3 (da) 2006-04-18
CN1274715C (zh) 2006-09-13
AU2001250318B2 (en) 2005-09-08
CZ303552B6 (cs) 2012-12-05
PL206818B1 (pl) 2010-09-30
US6627604B2 (en) 2003-09-30
ES2254394T3 (es) 2006-06-16
US20010031857A1 (en) 2001-10-18
HUP0204584A3 (en) 2005-09-28
RU2002125877A (ru) 2004-01-10
KR100997073B1 (ko) 2010-11-30
JP2004512257A (ja) 2004-04-22
EP1261625B1 (en) 2005-12-21
HRP20020703B1 (en) 2011-01-31
AU5031801A (en) 2001-09-12
SK287310B6 (sk) 2010-06-07
HRP20020703A2 (en) 2004-12-31
KR20020077508A (ko) 2002-10-11
NO20024105D0 (no) 2002-08-28
CA2401032A1 (en) 2001-09-07
ZA200206841B (en) 2003-07-03
CY1105550T1 (el) 2010-07-28
CN1406243A (zh) 2003-03-26
CA2401032C (en) 2012-04-10
JP4787449B2 (ja) 2011-10-05
EP1261625A2 (en) 2002-12-04
EP1130027A1 (de) 2001-09-05
MXPA02007845A (es) 2002-11-29
PL358300A1 (en) 2004-08-09
HU228067B1 (en) 2012-09-28
BR0108757A (pt) 2002-12-10
HK1052712B (zh) 2007-01-12
HUP0204584A2 (hu) 2003-04-28
AR029808A1 (es) 2003-07-16
HK1052712A1 (en) 2003-09-26
WO2001064715A2 (en) 2001-09-07
ATE313556T1 (de) 2006-01-15
WO2001064715A3 (en) 2002-03-21
DE60116063T2 (de) 2006-08-03
SI1261625T1 (sl) 2006-04-30
MEP59108A (en) 2011-05-10

Similar Documents

Publication Publication Date Title
TWI319764B (en) Mercaptoacetylamide derivatives, a process for their preparation and their use
AU9181501A (en) Percarboxylated polysaccharides, and a process for their preparation
TWI315741B (en) A-isomaltosyltransferase, process for producing the same and use thereof
HUP0102833A3 (en) Cyclosporins, process for preparation thereof and their use
HUP0300327A3 (en) Percyquinnin, a process for its production and its use as a pharmaceutical
GB0014870D0 (en) Peptides
IL153079A0 (en) Neuroprotective peptides
HUP0301627A3 (en) Glass-ceramics, process for their preparation and use
HUP0302295A3 (en) Thienodibenzoazulene derivatives, process for their preparation and use thereof
GB0029777D0 (en) Peptides
AU5031801A (en) Memno peptides, a process for their preparation and their use
HUP0100146A3 (en) 3-(1-hydroxy-pentylidene)-5-nitro-3h-benzofuran-2-one, process for its preparation and use thereof
EP1273657A4 (en) NOVEL PROTEIN, METHOD FOR PRODUCTION AND USE
GB0030309D0 (en) Antibodies,Peptides,Analogs and uses thereof
GB0001825D0 (en) Peptides
IL152158A0 (en) A glycopeptide and preparation thereof
IL151216A0 (en) Pluraflavins and derivatives thereof, process for their preparation and use thereof
GB0007263D0 (en) Peptides
EP1331269A4 (en) NEW PROTEIN, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF
GB0030059D0 (en) Polypeptides, methods and means
EP1295940A4 (en) POLYPEPTIDES, THE APPLICATION THEREOF AND METHOD FOR THE PRODUCTION THEREOF
AU7660601A (en) Pseudo-metalloproteins, their preparation and use
GB0025775D0 (en) Antigenic peptides
GB0021475D0 (en) Anti-aniogenic peptides
GB0010327D0 (en) Peptides

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed